Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px

Product › Details

TLR agonist

	Next higher product group	immuno modulatory compound (IMO)
	Status	2006-10-26 development pc start
	Organisation	Dynavax Technologies Corporation (Nasdaq: DVAX)
	Group	Dynavax (Group)

Record changed: 2023-07-10

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for TLR agonist

[1] Kupando GmbH. (9/26/22). "Press Release: Kupando Raises €13 Million in Series A Funding Round". Schönefeld....
[2] Mologen AG. (8/5/19). "Press Release: Mologen AG Announces Top Line Data of Pivotal IMPALA Study in Metastatic Colorectal Cancer. Primary Endpoint Not Met". Berlin....
[3] Mologen AG. (3/27/19). "Press Release: Top Pharma Manager Stefan M. Manth, MD, to Become CEO of Mologen AG". Berlin....
[4] Mologen AG. (3/18/19). "Press Release: Early Departure of CEO". Berlin....
[5] Mologen AG. (1/17/19). "Press Release: Full Placement of Convertible Bond 2019/2027. Total Amount Issued: EUR2.7 Million, Maturity of 8 Years, Coupon of 6% p.a. [NOT FOR US, CA, JP, et al.]". Berlin....
[6] Mologen AG. (11/16/18). "Press Release: Mologen AG to Retain Rights to Lefitolimod – Termination of Negotiations with Oncologie Inc. and Assessment of All Strategic Options in the Light of a Likely Read-out of the Pivotal Phase III IMPALA Trial in 2019"...
[7] Mologen AG. (11/12/18). "Press Release: Lefitolimod – First Clinical Data in Combination with a Checkpoint Inhibitor and further Preclinical Results Presented at SITC 2018". Berlin....
[8] Mologen AG. (11/8/18). "Press Release: Implementation of Financing Measures and Publication of Study Results". Berlin....
[9] Aelix Therapeutics S.L.. (10/18/18). "Press Release: Aelix Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure"....
[10] Mologen AG. (9/27/18). "Press Release: Mologen AG Completes Capital Increase with Gross Proceeds of around EUR8 Million [NOT FOR RELEASE IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, et al.]". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]